{"pmid":32352306,"title":"ST-Elevation Myocardial Infarction in Patients with COVID-19: Clinical and Angiographic Outcomes.","text":["ST-Elevation Myocardial Infarction in Patients with COVID-19: Clinical and Angiographic Outcomes.","Circulation","Stefanini, Giulio G","Montorfano, Matteo","Trabattoni, Daniela","Andreini, Daniele","Ferrante, Giuseppe","Ancona, Marco","Metra, Marco","Curello, Salvatore","Maffeo, Diego","Pero, Gaetano","Cacucci, Michele","Assanelli, Emilio","Bellini, Barbara","Russo, Filippo","Ielasi, Alfonso","Tespili, Maurizio","Danzi, Gian Battista","Vandoni, Pietro","Bollati, Mario","Barbieri, Lucia","Oreglia, Jacopo","Lettieri, Corrado","Cremonesi, Alberto","Carugo, Stefano","Reimers, Bernhard","Condorelli, Gianluigi","Chieffo, Alaide","32352306"],"journal":"Circulation","authors":["Stefanini, Giulio G","Montorfano, Matteo","Trabattoni, Daniela","Andreini, Daniele","Ferrante, Giuseppe","Ancona, Marco","Metra, Marco","Curello, Salvatore","Maffeo, Diego","Pero, Gaetano","Cacucci, Michele","Assanelli, Emilio","Bellini, Barbara","Russo, Filippo","Ielasi, Alfonso","Tespili, Maurizio","Danzi, Gian Battista","Vandoni, Pietro","Bollati, Mario","Barbieri, Lucia","Oreglia, Jacopo","Lettieri, Corrado","Cremonesi, Alberto","Carugo, Stefano","Reimers, Bernhard","Condorelli, Gianluigi","Chieffo, Alaide"],"date":"2020-05-01T11:00:00Z","year":2020,"_id":"32352306","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.1161/CIRCULATIONAHA.120.047525","keywords":["covid-19","sars-cov-2","acute myocardial infarction","coronary angiography"],"topics":["Diagnosis"],"weight":1,"_version_":1666138495720095744,"score":9.490897,"similar":[{"pmid":32473051,"title":"Massive coronary thrombosis caused primary percutaneous coronary intervention to fail in a COVID-19 patient with ST-elevation myocardial infarction.","text":["Massive coronary thrombosis caused primary percutaneous coronary intervention to fail in a COVID-19 patient with ST-elevation myocardial infarction.","COVID-19 is a new viral infection that has a significant impact on global health and economy. Because of its rapid spread worldwide, it may influence the prognosis of other medical conditions, such as ST-segment elevation myocardial infarction (STEMI). We report a case of a 58-year female patient admitted with an infero-posterior STEMI on the background of recently positive COVID-19 swab. Reperfusion was attempted through primary PCI but unfortunately failed to restore coronary blood flow due to massive thrombotic burden despite several attempts of balloon dilatation and aspiration thrombectomy. She sadly died later on because of hemodynamic deterioration. This scenario raises concerns about Neutrophil Extracellular Traps (NETS) which might potentially have propagated inflammation and thrombosis via platelets' aggregation leading to enhanced coagulopathy and massive coronary thrombosis. Therefore, we suggest primary PCI as the first-choice of revascularization in patients with combined COVID-19 and STEMI. Additionally, we emphasize on the importance of using the potent new generation P2Y12 inhibitors along with GPIIb/IIIa inhibitors in every STEMI patient with COVID-19 to achieve favorable conditions for primary PCI as well as favorable outcomes after stent implantation.","Catheter Cardiovasc Interv","Seif, Sherif","Ayuna, Ahmed","Kumar, Abhishek","Macdonald, John","32473051"],"abstract":["COVID-19 is a new viral infection that has a significant impact on global health and economy. Because of its rapid spread worldwide, it may influence the prognosis of other medical conditions, such as ST-segment elevation myocardial infarction (STEMI). We report a case of a 58-year female patient admitted with an infero-posterior STEMI on the background of recently positive COVID-19 swab. Reperfusion was attempted through primary PCI but unfortunately failed to restore coronary blood flow due to massive thrombotic burden despite several attempts of balloon dilatation and aspiration thrombectomy. She sadly died later on because of hemodynamic deterioration. This scenario raises concerns about Neutrophil Extracellular Traps (NETS) which might potentially have propagated inflammation and thrombosis via platelets' aggregation leading to enhanced coagulopathy and massive coronary thrombosis. Therefore, we suggest primary PCI as the first-choice of revascularization in patients with combined COVID-19 and STEMI. Additionally, we emphasize on the importance of using the potent new generation P2Y12 inhibitors along with GPIIb/IIIa inhibitors in every STEMI patient with COVID-19 to achieve favorable conditions for primary PCI as well as favorable outcomes after stent implantation."],"journal":"Catheter Cardiovasc Interv","authors":["Seif, Sherif","Ayuna, Ahmed","Kumar, Abhishek","Macdonald, John"],"date":"2020-05-31T11:00:00Z","year":2020,"_id":"32473051","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1002/ccd.29050","keywords":["acute myocardial infarction","antithrombotic treatment","neutrophil extracellular traps","primary percutaneous coronary intervention","viral infection"],"topics":["Case Report"],"weight":1,"_version_":1668255193450414080,"score":94.90994},{"pmid":32352633,"title":"Insights for increased risk of failed fibrinolytic therapy and stent thrombosis associated with COVID-19 in ST-segment elevation myocardial infarction patients.","text":["Insights for increased risk of failed fibrinolytic therapy and stent thrombosis associated with COVID-19 in ST-segment elevation myocardial infarction patients.","Important health resources are dedicated worldwide to the management of COVID-19. This new disease, due to its large diffusion, may significantly hamper the prognosis of other pathologies, such as ST-segment elevation myocardial infarction (STEMI) because of (a) a possible direct negative impact and (b) shortage of first response medical resources and increased delays to reperfusion. We report the case of a 68-year-old man admitted for anterior STEMI and asymptomatic COVID-19. Due to extended transportation delays to a cathlab, he received intravenous fibrinolytic therapy, which failed. Reperfusion was achieved with rescue coronary angioplasty, but the patient experienced two episodes of acute stent thrombosis at 2- and 36-hr following admission and despite optimal medical therapy. He finally died because of cardiogenic shock. This raises concerns about a possible increase in platelet aggregability associated with COVID-19 leading to an increased risk of stent thrombosis, particularly in the context of STEMI. This pleads for the promotion of primary coronary angioplasty as the first-choice revascularization technique in this population and the use of new generation P2Y12 inhibitors. In addition, the use of GPIIb/IIIa inhibitors may be considered in every STEMI patient with COVID-19 to prevent the risk of acute stent thrombosis.","Catheter Cardiovasc Interv","Lacour, Thibaud","Semaan, Carl","Genet, Thibaud","Ivanes, Fabrice","32352633"],"abstract":["Important health resources are dedicated worldwide to the management of COVID-19. This new disease, due to its large diffusion, may significantly hamper the prognosis of other pathologies, such as ST-segment elevation myocardial infarction (STEMI) because of (a) a possible direct negative impact and (b) shortage of first response medical resources and increased delays to reperfusion. We report the case of a 68-year-old man admitted for anterior STEMI and asymptomatic COVID-19. Due to extended transportation delays to a cathlab, he received intravenous fibrinolytic therapy, which failed. Reperfusion was achieved with rescue coronary angioplasty, but the patient experienced two episodes of acute stent thrombosis at 2- and 36-hr following admission and despite optimal medical therapy. He finally died because of cardiogenic shock. This raises concerns about a possible increase in platelet aggregability associated with COVID-19 leading to an increased risk of stent thrombosis, particularly in the context of STEMI. This pleads for the promotion of primary coronary angioplasty as the first-choice revascularization technique in this population and the use of new generation P2Y12 inhibitors. In addition, the use of GPIIb/IIIa inhibitors may be considered in every STEMI patient with COVID-19 to prevent the risk of acute stent thrombosis."],"journal":"Catheter Cardiovasc Interv","authors":["Lacour, Thibaud","Semaan, Carl","Genet, Thibaud","Ivanes, Fabrice"],"date":"2020-05-01T11:00:00Z","year":2020,"_id":"32352633","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.1002/ccd.28948","keywords":["acute myocardial infarction","antithrombotic treatment","viral infection"],"topics":["Case Report"],"weight":1,"_version_":1666138495758893056,"score":92.81715},{"pmid":32472994,"title":"ST-elevation myocardial infarction in the COVID-19 era.","text":["ST-elevation myocardial infarction in the COVID-19 era.","Minerva Cardioangiol","Versaci, Francesco","Scappaticci, Massimiliano","Calcagno, Simone","Del Prete, Armando","Romeo, Francesco","Peruzzi, Mariangela","Cavarretta, Elena","Frati, Giacomo","32472994"],"journal":"Minerva Cardioangiol","authors":["Versaci, Francesco","Scappaticci, Massimiliano","Calcagno, Simone","Del Prete, Armando","Romeo, Francesco","Peruzzi, Mariangela","Cavarretta, Elena","Frati, Giacomo"],"date":"2020-05-31T11:00:00Z","year":2020,"_id":"32472994","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.23736/S0026-4725.20.05343-8","topics":["Prevention"],"weight":1,"_version_":1668255193410568192,"score":85.771515},{"pmid":32471712,"title":"Treatment of ST-segment elevation myocardial infarction during COVID-19 pandemic.","text":["Treatment of ST-segment elevation myocardial infarction during COVID-19 pandemic.","The number of cases of the coronavirus-induced disease-2019 (COVID-19) continues to increase exponentially worldwide. In this crisis situation, the management of ST-segment elevation myocardial infarction (STEMI) is challenging. In this review, we outline the risk and benefits of primary PCI vs. thrombolysis for STEMI. While thrombolysis may seem like a good choice, many patients have a contraindication and could end-up using more resources. Also, with a high probability of the angiogram showing non-obstructed coronary arteries during acute infections, primary PCI should be the preferred strategy.","Cardiovasc Revasc Med","Yerasi, Charan","Case, Brian C","Forrestal, Brian J","Chezar-Azerrad, Chava","Hashim, Hayder","Ben-Dor, Itsik","Satler, Lowell F","Mintz, Gary S","Waksman, Ron","32471712"],"abstract":["The number of cases of the coronavirus-induced disease-2019 (COVID-19) continues to increase exponentially worldwide. In this crisis situation, the management of ST-segment elevation myocardial infarction (STEMI) is challenging. In this review, we outline the risk and benefits of primary PCI vs. thrombolysis for STEMI. While thrombolysis may seem like a good choice, many patients have a contraindication and could end-up using more resources. Also, with a high probability of the angiogram showing non-obstructed coronary arteries during acute infections, primary PCI should be the preferred strategy."],"journal":"Cardiovasc Revasc Med","authors":["Yerasi, Charan","Case, Brian C","Forrestal, Brian J","Chezar-Azerrad, Chava","Hashim, Hayder","Ben-Dor, Itsik","Satler, Lowell F","Mintz, Gary S","Waksman, Ron"],"date":"2020-05-31T11:00:00Z","year":2020,"_id":"32471712","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1016/j.carrev.2020.05.027","keywords":["covid-19","fibrinolytics","primary percutaneous coronary intervention","stemi"],"topics":["Prevention"],"weight":1,"_version_":1668255193421053952,"score":77.98041},{"pmid":32311816,"title":"Management of Acute Myocardial Infarction During the COVID-19 Pandemic.","text":["Management of Acute Myocardial Infarction During the COVID-19 Pandemic.","The worldwide pandemic caused by the novel acute respiratory syndrome coronavirus 2 (SARS-CoV2) has resulted in a new and lethal disease termed coronavirus disease 2019 (COVID-19). Although there is an association between cardiovascular disease and COVID-19, the majority of patients who need cardiovascular care for the management of ischemic heart disease may not be infected with COVID-19. The objective of this document is to provide recommendations for a systematic approach for the care of patients with an acute myocardial infarction (AMI) during the COVID-19 pandemic. There is a recognition of two major challenges in providing recommendations for AMI care in the COVID-19 era. Cardiovascular manifestations of COVID-19 are complex with patients presenting with AMI, myocarditis simulating a ST-elevation MI presentation, stress cardiomyopathy, non-ischemic cardiomyopathy, coronary spasm, or nonspecific myocardial injury and the prevalence of COVID-19 disease in the US population remains unknown with risk of asymptomatic spread. This document addresses the care of these patients focusing on 1) the varied clinical presentations; 2) appropriate personal protection equipment (PPE) for health care workers; 3) role of the Emergency Department, Emergency Medical System and the Cardiac Catheterization Laboratory; and 4) Regional STEMI systems of care. During the COVID-19 pandemic, primary PCI remains the standard of care for STEMI patients at PCI capable hospitals when it can be provided in a timely fashion, with an expert team outfitted with PPE in a dedicated CCL room. A fibrinolysis-based strategy may be entertained at non-PCI capable referral hospitals or in specific situations where primary PCI cannot be executed or is not deemed the best option. This article is protected by copyright. All rights reserved.","Catheter Cardiovasc Interv","Mahmud, Ehtisham","Dauerman, Harold L","Welt, Frederick Gp","Messenger, John C","Rao, Sunil V","Grines, Cindy","Mattu, Amal","Kirtane, Ajay J","Jauhar, Rajiv","Meraj, Perwaiz","Rokos, Ivan C","Rumsfeld, John S","Henry, Timothy D","32311816"],"abstract":["The worldwide pandemic caused by the novel acute respiratory syndrome coronavirus 2 (SARS-CoV2) has resulted in a new and lethal disease termed coronavirus disease 2019 (COVID-19). Although there is an association between cardiovascular disease and COVID-19, the majority of patients who need cardiovascular care for the management of ischemic heart disease may not be infected with COVID-19. The objective of this document is to provide recommendations for a systematic approach for the care of patients with an acute myocardial infarction (AMI) during the COVID-19 pandemic. There is a recognition of two major challenges in providing recommendations for AMI care in the COVID-19 era. Cardiovascular manifestations of COVID-19 are complex with patients presenting with AMI, myocarditis simulating a ST-elevation MI presentation, stress cardiomyopathy, non-ischemic cardiomyopathy, coronary spasm, or nonspecific myocardial injury and the prevalence of COVID-19 disease in the US population remains unknown with risk of asymptomatic spread. This document addresses the care of these patients focusing on 1) the varied clinical presentations; 2) appropriate personal protection equipment (PPE) for health care workers; 3) role of the Emergency Department, Emergency Medical System and the Cardiac Catheterization Laboratory; and 4) Regional STEMI systems of care. During the COVID-19 pandemic, primary PCI remains the standard of care for STEMI patients at PCI capable hospitals when it can be provided in a timely fashion, with an expert team outfitted with PPE in a dedicated CCL room. A fibrinolysis-based strategy may be entertained at non-PCI capable referral hospitals or in specific situations where primary PCI cannot be executed or is not deemed the best option. This article is protected by copyright. All rights reserved."],"journal":"Catheter Cardiovasc Interv","authors":["Mahmud, Ehtisham","Dauerman, Harold L","Welt, Frederick Gp","Messenger, John C","Rao, Sunil V","Grines, Cindy","Mattu, Amal","Kirtane, Ajay J","Jauhar, Rajiv","Meraj, Perwaiz","Rokos, Ivan C","Rumsfeld, John S","Henry, Timothy D"],"date":"2020-04-21T11:00:00Z","year":2020,"_id":"32311816","source":"PubMed","week":"202017|Apr 20 - Apr 26","doi":"10.1002/ccd.28946","keywords":["covid-19","stemi","acute myocardial infarction","emergency medical system","fibrinolysis","percutaneous coronary intervention"],"locations":["US"],"countries":["United States"],"countries_codes":["USA|United States"],"topics":["Prevention"],"weight":1,"_version_":1666138491218558976,"score":76.65776}]}